News

BreathSpec® and the fight against AMR

The Imspex Group’s BreathSpec® technology is well-placed to play a leading role in combatting antimicrobial resistance by helping healthcare practitioners to differentiate between bacterial and viral causes of respiratory infection. This would better allow the right antibiotic to be prescribed to the right patient at the right time and in the right dose , thereby […]

BreathSpec® differentiates COVID-19 from other infections

BreathSpec® differentiates COVID-19 from other infections

Findings of a feasibility study into the potential for breath analysis to help doctors to differentiate between COVID-19 and other respiratory conditions were published in The Lancet on 24 October 2020. The Imspex Group’s BreathSpec® instrument showed clusters of breath compounds reflecting the effects of COVID-19’s multi-system nature. Similar clusters were found independently across research […]

IMSPEX completes SMART Cymru project

IMSPEX completes SMART Cymru project

IMSPEX is pleased to have completed a Welsh Government- and ERDF-backed Technical and Commercial Feasibility (TCF) study focused on translating innovative and high-impact medical technology into solutions that can be implemented and scaled to generate health, wellbeing and economic prosperity within Wales. This study contributed to the Welsh Government’s aim of ensuring that resources an […]

Monitoring of Toxic Industrial Chemicals (TICs)

chemical plant

Rapid Monitoring of Dimethyl Sulfate (DMS) in Chemical Plants using GC-IMS Technology Toxic industrial chemicals (TICs) or materials (TIMs) are substances that exhibit harmful effects on humans and are common in manufacturing facilities, chemical plants, maintenance areas or general storage areas. Exposure to those chemicals are seriously harmful especially after multiple low-level exposures. Dimethyl sulfate […]